Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Discovery

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2159-8290.CD-12-0383PMID 23519018PMCID PMC3716460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T-cell therapy at the threshold

  2012cited by this paper
• Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

  2012cited by this paper
• Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy

  2012cited by this paper
• Adoptive immunotherapy for cancer: harnessing the T cell response

  2012cited by this paper
• Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

  2012cited by this paper
• Inflammation and immune surveillance in cancer.

  2012cited by this paper
• A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells

  2011cited by this paper
• Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

  2011cited by this paper
• Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.

  2011cited by this paper
• Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice

  2011cited by this paper
• CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

  2011cited by this paper
• Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

  2011cited by this paper
• Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy.

  2011cited by this paper
• The Impact of Ex Vivo Clinical Grade Activation Protocols on Human T-cell Phenotype and Function for the Generation of Genetically Modified Cells for Adoptive Cell Transfer Therapy

  2010cited by this paper
• Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses

  2010cited by this paper
• Pharmacologic Induction of CD8+ T Cell Memory: Better Living Through Chemistry

  2009cited by this paper
• Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells.

  2009cited by this paper
• Comparison of interlaboratory variation in absolute T‐cell counts by single‐platform and optimized dual‐platform methods

  2009cited by this paper
• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

  2009cited by this paper
• Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

  2009cited by this paper
• T-cell quality in memory and protection: implications for vaccine design

  2008cited by this paper
• Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

  2008cited by this paper
• Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008cited by this paper
• Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

  2008cited by this paper
• Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

  2008cited by this paper
• CD8+ T cell efficacy in vaccination and disease

  2008cited by this paper
• Phenotype and function of human T lymphocyte subsets: Consensus and issues

  2008cited by this paper
• Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

  2007cited by this paper
• HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

  2006cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays

  2006cited by this paper
• Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

  2005cited by this paper
• Determinant spreading and tumor responses after peptide-based cancer immunotherapy.

  2003cited by this paper
• The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• [New guidelines to evaluate the response to treatment in solid tumors].

  2000cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Robust text-independent speaker identification using Gaussian mixture speaker models

  1995cited by this paper
• Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.

  1995cited by this paper
• Applied Multivariate Statistical Analysis

  1983cited by this paper

• Pre-existing activation states shape functional heterogeneity of human Vγ9Vδ2 T cells.

  2026cites this paper
• Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons

  2025cites this paper
• Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics

  2025cites this paper
• PiP-plex: A Particle-in-Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells

  2025cites this paper
• Specific Stimulation and Multiplex Secretion Analysis of T Cells Using a Suspendable Hydrogel Platform Enables Immunophenotyping at the Single-Cell Scale.

  2025cites this paper
• Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

  2025cites this paper
• Biomolecule Conjugation Strategy for HAGM Cryogels to Create 3D Immune Niches that Induce Multifunctional T Cells

  2025cites this paper
• Immunologic specificity in glioblastoma: Antigen discovery and translational implications

  2025cites this paper
• Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy

  2024cites this paper
• Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery.

  2024cites this paper
• Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score

  2024cites this paper
• The potential and promise for clinical application of adoptive T cell therapy in cancer

  2024cites this paper
• Harnessing the Transcriptional Signatures of CAR-T-Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies

  2024cites this paper
• Microfluidic platform for omics analysis on single cells with diverse morphology and size: A review.

  2024cites this paper
• Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC

  2023cites this paper
• Three-dimensional isotropic imaging of live suspension cells enabled by droplet microvortices

  2023cites this paper
• Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

  2023cites this paper
• Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours

  2023cites this paper
• Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

  2023cites this paper
• Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies

  2023cites this paper
• A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer.

  2023cites this paper
• Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer

  2023cites this paper
• Applying single‐cell highly multiplexed secretome proteomics to characterize immunotherapeutic products and predict clinical responses

  2023cites this paper
• Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

  2023cites this paper
• Defining T cell receptor repertoires using nanovial-based affinity and functional screening

  2023cites this paper
• The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)

  2022cites this paper
• Reprogramming immune cells activity by furin-like enzymes as emerging strategy for enhanced immunotherapy in cancer

  2022cites this paper
• Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy

  2022cites this paper
• Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy

  2022cites this paper
• Integrating Micro and Nano Technologies for Cell Engineering and Analysis: Toward the Next Generation of Cell Therapy Workflows.

  2022cites this paper
• Single-cell sorting based on secreted products for functionally defined cell therapies

  2022cites this paper
• Single-Cell Proteomics: The Critical Role of Nanotechnology

  2022cites this paper
• Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies.

  2022cites this paper
• Sorting single T cells based on secreted cytokines and surface markers using hydrogel nanovials

  2022cites this paper
• Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models

  2022cites this paper
• IL-2 secretion-based sorting of single T cells using high-throughput microfluidic on-cell cytokine capture.

  2022cites this paper
• Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19

  2022cites this paper
• Single cell sequencing analysis uncovers genetics-influenced CD16+monocytes and memory CD8+T cells involved in severe COVID-19

  2022cites this paper
• HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma

  2022cites this paper
• Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses

  2022cites this paper
• Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas

  2021cites this paper
• Understanding cell‐cell communication and signaling in the colorectal cancer microenvironment

  2021cites this paper
• Bombyx batryticatus Protein-Rich Extract Induces Maturation of Dendritic Cells and Th1 Polarization: A Potential Immunological Adjuvant for Cancer Vaccine

  2021influential citation
• Interfacing droplet microfluidics with antibody barcodes for multiplexed single-cell protein secretion profiling.

  2021cites this paper
• Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells

  2021cites this paper
• Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30

  2021cites this paper
• Interfacing Biomaterials with Synthetic T Cell Immunity

  2021cites this paper
• Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19

  2021cites this paper
• Single-Cell Multiomics Analysis for Drug Discovery

  2021cites this paper
• Application of a simple unstructured kinetic and cost of goods models to support T‐cell therapy manufacture

  2021cites this paper
• An overview of multiplexed analyses of CAR T-cell therapies: insights and potential

  2021cites this paper
• Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy

  2021cites this paper
• Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities

  2021cites this paper
• Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers

  2021cites this paper
• Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adults

  2021cites this paper
• Translating Cancer Molecular Variability into Personalized Information Using Bulk and Single Cell Approaches

  2020cites this paper
• Advanced Cell Mapping Visualizations for Single Cell Functional Proteomics Enabling Patient Stratification

  2020cites this paper
• CD29 identifies IFN-γ–producing human CD8+ T cells with an increased cytotoxic potential

  2020cites this paper
• Microfluidics for Immuno‐oncology

  2020cites this paper
• Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories

  2020cites this paper
• The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

  2020cites this paper
• CRISPR-mediated deletion of the Protein tyrosine phosphatase, non-receptor type 22 (PTPN22) improves human T cell function for adoptive T cell therapy

  2020cites this paper
• Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy

  2020cites this paper
• Biomarkers for predicting the outcome of various cancer immunotherapies.

  2020cites this paper
• Development of Proximity Ligation Assay variants for single cell proteomics

  2020cites this paper
• Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

  2020cites this paper
• Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection

  2020cites this paper
• Single-Cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies.

  2020cites this paper
• The Resistance Mechanisms of Lung Cancer Immunotherapy

  2020cites this paper
• Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice

  2020cites this paper
• Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

  2020cites this paper
• New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia

  2020cites this paper
• Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist

  2020cites this paper
• Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.

  2020cites this paper
• Single-cell analysis targeting the proteome

  2020cites this paper
• University of Southern Denmark Rational design of a trimeric April-based CAR-binding domain enables efficient targeting of multiple myeloma Schmidts,

  2019cites this paper
• Single-Cell Omics Analyses Enabled by Microchip Technologies.

  2019cites this paper
• CD29 marks superior cytotoxic human T cells

  2019cites this paper
• The Discovery of Biomarkers in Cancer Immunotherapy

  2019cites this paper
• National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.

  2019cites this paper
• T Cell Dysfunction in Cancer Immunity and Immunotherapy

  2019cites this paper
• T Cell Receptors for Gene Transfer in Adoptive T Cell Therapy.

  2019cites this paper
• Framing technology challenges associated with improving cancer immunotherapies.

  2019cites this paper
• Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.

  2019cites this paper
• NCI Alliance for Nanotechnology in Cancer – Catalysing Research and Translation Towards Novel Cancer Diagnostics and Therapeutics

  2019influential citation
• Annual Review of Biomedical Engineering Single-Cell Omics Analyses Enabled by Microchip Technologies

  2019cites this paper
• Microfluidic Probes for Single‐Cell Proteomic Analysis

  2018cites this paper
• Defining Cell Identity with Single‐Cell Omics

  2018cites this paper
• Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system

  2018cites this paper
• Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells associate with clinical outcomes in NHL Running Head: Polyfunctional CAR T cell-associated clinical outcomes

  2018cites this paper
• Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products

  2018cites this paper
• Single-Cell Protein Assays: A Review.

  2018cites this paper
• The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer.

  2018cites this paper
• T Cell Dysfunction in Cancer.

  2018cites this paper
• Multiplexed profiling of single-cell extracellular vesicles secretion

  2018cites this paper
• A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication

  2018cites this paper
• A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

  2018cites this paper
• Biochips—New Platforms for Cell‐Based Immunological Assays

  2018cites this paper
• Single-cell technologies for profiling T cells to enable monitoring of immunotherapies.

  2018cites this paper
• Enhanced TLR2 responses in multiple sclerosis

  2018cites this paper